Prolactin (PRL)-dependent signaling occurs as the result of ligand-induced dimerization of the prolactin receptor, their interaction can modulate the endocrine and autocrine effects of prolactin in normal tissue and cancer [46, 47]. The gene discussed is PRL; the disease is cancer.